CD44 and triple-negative breast carcinoma: In contrast, the use of HA as a targeting ligand in the albumin nanoparticles, PP-HA-BSA-NPs, significantly improved drug delivery in CD44-expressing triple-negative breast cancer and colorectal cancer cells.